PRENUMBRA
CUV901
Phase 2 small_molecule active
Quick answer
PRENUMBRA for Parkinson's Disease is a Phase 2 program (small_molecule) at Clinuvel Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Clinuvel Europe Limited
- Indication
- Parkinson's Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active